Blood Testing Market by Type, Application, End-User

List of Tables

[184 Pages Report] The Blood Testing Market size was estimated at USD 94.49 billion in 2023 and expected to reach USD 100.02 billion in 2024, at a CAGR 6.34% to reach USD 145.37 billion by 2030.

Global Blood Testing Market

KEY MARKET STATISTICS
Base Year [2023]	USD 94.49 billion
Estimated Year [2024]	USD 100.02 billion
Forecast Year [2030]	USD 145.37 billion
CAGR (%)	6.34%

Blood testing is a clinical procedure that involves analyzing a blood sample in a laboratory to assess the general state of health, detect the presence of viral or bacterial infections, determine the functioning of various organs, and screen for genetic conditions. Blood tests are critical tools for preventive medicine and medical diagnostics, providing valuable data for early disease detection and management. Blood tests have various applications in various medical and healthcare domains. Routine testing for metabolic functions, increasing prevalence of infectious disease, and ongoing investments in blood testing facilities have enhanced the need for advanced blood testing solutions. However, strict regulatory requirements for approval and high costs associated with advanced testing technologies may restrict product penetration worldwide. In addition, a lack of trained professionals to conduct and interpret complex blood tests may limit the use of blood testing solutions. Nevertheless, the improved testing technologies that provide quicker, more accurate, and less invasive testing and Increased spending on healthcare infrastructure and diagnostics are expected to create growth opportunities for the blood testing market in the coming years.

Regional Insights

The blood testing market in the Americas is highly developing and characterized by advanced healthcare systems and higher consumer awareness of health conditions. A growing prevalence of chronic diseases, an aging population, and the presence of major healthcare companies elevate the need for diagnostic services such as blood testing. European Union (EU) countries exhibit a strong need for blood testing due to the high healthcare standards and the presence of national healthcare systems. An increasing focus on preventive care and the prevalence of chronic diseases among aging populations drives the market. Furthermore, the EU's stringent regulatory framework ensures high-quality blood testing procedures and equipment standards. The Middle East showcases rapid advancement due to investments in healthcare infrastructure, while many African regions face challenges, including accessibility and affordability of blood testing products. The Asia Pacific region represents a rapidly growing blood testing market due to large population bases, increasing healthcare expenditures, and rapid urbanization. The ongoing innovation and development of consumer-friendly blood testing products are expected to drive the blood testing market in Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., bioMerieux S.A., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Basic Metabolic Panels
- Complete Blood Count Tests
- Complete Metabolic Panels
- Electrolyte Panels
Application
- Allergies
- Autoimmune Diseases
- Cancer/Noncancerous Blood Disorders
- Endocrine System Disorders
- Heart Diseases
End-User
- Home Care
- Hospital & Clinics
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Testing Market?

3. What are the technology trends and regulatory frameworks in the Blood Testing Market?

4. What is the market share of the leading vendors in the Blood Testing Market?

5. Which modes and strategic moves are suitable for entering the Blood Testing Market?

Product Code: MRR-144C638C91E0

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Blood Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
  - 5.1.1.2. Government initiatives in blood testing checkup campaigns
  - 5.1.1.3. Significant expansion of blood testing facilities worldwide
- 5.1.2. Restraints
  - 5.1.2.1. Changing costs of raw materials and issues of product recalls
- 5.1.3. Opportunities
  - 5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
  - 5.1.3.2. Advancements in blood testing products
- 5.1.4. Challenges
  - 5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
5.2. Market Segmentation Analysis
- 5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
- 5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
- 5.2.3. End-User: Emerging penetration of blood testing products in home care settings
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Blood Testing Market, by Type

6.1. Introduction
6.2. Basic Metabolic Panels
6.3. Complete Blood Count Tests
6.4. Complete Metabolic Panels
6.5. Electrolyte Panels

7. Blood Testing Market, by Application

7.1. Introduction
7.2. Allergies
7.3. Autoimmune Diseases
7.4. Cancer/Noncancerous Blood Disorders
7.5. Endocrine System Disorders
7.6. Heart Diseases

8. Blood Testing Market, by End-User

8.1. Introduction
8.2. Home Care
8.3. Hospital & Clinics

9. Americas Blood Testing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Blood Testing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Blood Testing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
  - 12.3.1.1. Bert Vogelstein's Latest Blood Testing Startup Gets Acquired for USD 450 Million
- 12.3.2. Agreement, Collaboration, & Partnership
  - 12.3.2.1. Diagnostics Companies Enter Agreement to Expand Access to Blood-Based IsoPSA Test
- 12.3.3. New Product Launch & Enhancement
  - 12.3.3.1. Labcorp Launches 3-Part Blood Test for Alzheimer's

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. A. Menarini Diagnostics s.r.l.
- 13.1.2. Abbott Laboratories
- 13.1.3. ACON Laboratories, Inc.
- 13.1.4. ARKRAY, Inc.
- 13.1.5. B. Braun Melsungen AG
- 13.1.6. Becton Dickinson & Company
- 13.1.7. Bio-Rad Laboratories Inc.
- 13.1.8. bioMerieux S.A.
- 13.1.9. Danaher Corporation
- 13.1.10. F. Hoffmann-La Roche AG
- 13.1.11. Johnson & Johnson Services, Inc.
- 13.1.12. Medtronic PLC
- 13.1.13. Merck KGaA
- 13.1.14. Nipro Corporation
- 13.1.15. Nova Biomedical Corporation
- 13.1.16. Novo Nordisk A/S
- 13.1.17. Omnipod by Insulet Corporation
- 13.1.18. Quest Diagnostic
- 13.1.19. Randox Laboratories Ltd.
- 13.1.20. Siemens AG
- 13.1.21. Terumo Corporation
- 13.1.22. Thermo Fisher Scientific, Inc.
- 13.1.23. Trinity Biotech PLC
- 13.1.24. Trividia Health, Inc.
- 13.1.25. Ypsomed AG
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing